Maximiliano Van Kooten

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

Frances A. Shepherd, José Rodrigues Pereira, Tudor–Eliade Ciuleanu et al. · New England Journal of Medicine · 2005 · 5.5K citations · Full text

Medicine, Oncology, Pharmacology +15

A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer

José Rodrigues-Pereira, Joo-Hang Kim, Manuel Magallanes et al. · Journal of Thoracic Oncology · 2011 · 95 citations · Full text

Medicine, Oncology, Pharmacology +10

A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients

Alberto Zori Comba, C. Blajman, Eduardo Richardet et al. · European Journal of Cancer · 2001 · 37 citations

Medicine, Oncology, Pharmacotherapy +14

Single-agent gemcitabine in pretreated patients with non-small-cell lung cancer: results of an Argentinean multicentre phase II trial

Maximiliano Van Kooten, G. Traine, Gabriela Cinat et al. · British Journal of Cancer · 1999 · 23 citations · Full text

Medicine, Oncology, Pharmacology +14

Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancer

José Rodrigues Pereira, Luis Fein, Auro del Giglio et al. · Lung Cancer · 2007 · 11 citations · Full text

Medicine, Oncology, Pharmacology +13